By Professor Jo-anne E Brien

Journal articles

Gallego G; Taylor S; Brien JE, 2004, 'Equity of access to high cost drugs (HCDS): A case study', Clinical and Experimental Pharmacology and Physiology, 31, pp. A225 - A225

Sabet P; Maxwell D; Brien JE, 2004, 'Evaluation of Mycophenolate for Unregistered Indications', Journal of Pharmacy Practice and Research, 34, pp. 36 - 37

Moles R; Brien JE; Benrimoj C, 2004, 'Factors influencing pharmaceutical service provision within NSW private hospitals', Australian Pharmacist, 23, pp. 238 - 243

Easton KL; Chapman CB; Brien JE, 2004, 'Frequency of Characteristics of hospital admissions associated with drug related problems in paediatrics', British Journal of Clinical Pharmacology, 57, pp. 611 - 615

Gallego G; Melocco T; Taylor S; Brien JE, 2004, 'Impact of High-Cost Drugs for Individual Patient Use', Journal of Pharmacy Practice and Research, 34, pp. 100 - 103

Lawler C; Welch SA; Brien JE, 2004, 'Omitted Medication Doses: Frequency and Severity', Journal of Pharmacy Practice and Research, 34, pp. 174 - 177

Kay OC; Brien JE, 2004, 'Pharmacist prescribing: Review of the literature', Journal of Pharmacy Practice and Research, 34, pp. 300 - 304

Chaar B; Brien JA; Krass I, 2003, 'Professional ethics in pharmacy', Australian Journal of Pharmacy, 84, pp. 856 - 859

Brien JAE; Melocco T, 2003, 'Pharmacy leadership and multidisciplinary partnerships [3]', Journal of Pharmacy Practice and Research, 33, pp. 158 - 159

Slader CA; Brien JAE, 2003, 'The graduates' forum [1]', Journal of Pharmacy Practice and Research, 33, pp. 157

Easton-Carter KL; Chapman CB; Brien JE, 2003, 'Emergency department attendances associated with drug-related problems in paediatrics', Journal of Paediatrics and Child Health, 39, pp. 124 - 129, http://dx.doi.org/10.1046/j.1440-1754.2003.00103.x

Easton-Carter KL; Chapman CB; Brien JAE, 2003, 'Adverse drug reactions in paediatrics: Are we getting the full picture?', Journal of Pharmacy Practice and Research, 33, pp. 106 - 110, http://dx.doi.org/10.1002/jppr2003332106

Brien JAE, 2003, 'Pharmacogenomics - Clinical and Social Implications', Journal of Pharmacy Practice and Research, 33, pp. 224 - 227, http://dx.doi.org/10.1002/jppr2003333224

Tan E; Day RO; Brien JE, 2003, 'Drug and therapeutics committees - are they fulfilling their potential to improve the quality use of medicines?', International Journal of Pharmacy Practice, 11, pp. 175 - 181

Bennett A; Brien JA, 2002, 'Community liaison pharmacist role in the multi-disciplinary care of heart failure patients', Australian Journal of Pharmacy, 83, pp. 740 - 743

Easton‐Carter KL; Chapman CB; Brien JE, 2002, 'Issues in the Interpretation and Design of Studies Investigating Drug‐Related Morbidity and Mortality', Journal of Pharmacy Practice and Research, 32, pp. 235 - 239, http://dx.doi.org/10.1002/jppr2002323235

Brien J, 2000, 'Pharmacy Practice Research', The Australian Journal of Hospital Pharmacy, 30, pp. 192 - 193, http://dx.doi.org/10.1002/jppr2000305192

McLennan DN; Dooley MJ; Brien JAE, 1999, 'Beneficial clinical outcomes resulting from pharmacist interventions', Journal of Oncology Pharmacy Practice, 5, pp. 184 - 189, http://dx.doi.org/10.1177/107815529900500404

Brien JE; Ford DA, 1999, 'A New Course in Clinical Pharmacy in Victoria', The Australian Journal of Hospital Pharmacy, 29, pp. 95 - 99, http://dx.doi.org/10.1002/jppr199929295

Brien J, 1999, 'Book Reviews', The Australian Journal of Hospital Pharmacy, 29, pp. 236 - 236, http://dx.doi.org/10.1002/jppr1999294236

McLennan DN; Dooley MJ; Brien JE, 1999, 'ICD‐10‐AM Activity Codes: An Opportunity for Standardisation', The Australian Journal of Hospital Pharmacy, 29, pp. 261 - 264, http://dx.doi.org/10.1002/jppr1999295261

McConachy KA; Brien JE, 1999, 'Monitoring Thyroxine Dosage with Serum Concentrations of Thyroid Stimulating Hormone', The Australian Journal of Hospital Pharmacy, 29, pp. 142 - 145, http://dx.doi.org/10.1002/jppr1999293142

Nawaratne S; Brien JAE; Seeman E; Fabiny R; Zalcberg J; Cosolo W; Angus P; Morgan DJ, 1998, 'Relationships among liver and kidney volumes, lean body mass and drug clearance', British Journal of Clinical Pharmacology, 46, pp. 447 - 452, http://dx.doi.org/10.1046/j.1365-2125.1998.00812.x

Easton KL; Parsons BJ; Starr M; Brien JAE, 1998, 'The incidence of drug-related problems as a cause of hospital admissions in children', Medical Journal of Australia, 169, pp. 356 - 359, http://dx.doi.org/10.5694/j.1326-5377.1998.tb126802.x

Rayner CR; Ioannides-Demos LL; Brien JAE; Liolios LL; Spicer WJ, 1998, 'Initial concentration-time profile of gentamicin determines efficacy against Enterobacter cloacae ATCC 13047', Antimicrobial Agents and Chemotherapy, 42, pp. 1370 - 1374, http://dx.doi.org/10.1128/aac.42.6.1370

Nawaratne S; Fabiny R; Brien JE; Zalcberg J; Cosolo W; Whan A; Morgan DJ, 1997, 'Accuracy of volume measurement using helical CT', Journal of Computer Assisted Tomography, 21, pp. 481 - 486, http://dx.doi.org/10.1097/00004728-199705000-00027

Campbell B; Brien JE, 1995, 'Pharmacokinetics in spinal cord injured patients', Australian Journal of Hospital Pharmacy, 25, pp. 327 - 332

Brien JA, 1993, 'Ototoxicity Associated with Salicylates: A Brief Review', Drug Safety, 9, pp. 143 - 148, http://dx.doi.org/10.2165/00002018-199309020-00006

Brien JA; Gaynor G; Hampson J, 1985, 'SHPA policy guidelines for pharmacy services to oncology units', Australian Journal of Hospital Pharmacy, 15

Brien JA; Gaynor G; Hampson J, 1984, 'Advisory labels for antineoplastic agents', Australian Journal of Hospital Pharmacy, 14, pp. 61 - 63

Back to profile page